+91 99104 22296 | info@pharmabridge.co.in
Home Products About Us Quality & Compliance Blog / Insights Contact Us
Oncology Intermediates
B2B Sourcing & Supply Partner

Lenalidomide Intermediates – Pharmaceutical Synthesis Building Blocks

Specialized Intermediates for Lenalidomide API Development

Heterocyclic & Aromatic Intermediate Grade • CAS #24666-56-6 / 98475-07-1 • Confirm per product (Live page lists ≥98.5%)

Pharmabridge supplies a focused range of Lenalidomide intermediates used in pharmaceutical synthesis, process development and commercial API manufacturing programs. Our listed range includes 3-Aminopiperidine-2,6-dione Hydrochloride and Methyl 2-(Bromomethyl)-3-nitrobenzoate. These compounds serve as important building blocks in synthetic routes associated with Lenalidomide, an immunomodulatory oncology API.

Specification-Based Sourcing Documentation Coordination Commercial B2B Supply
Rapid Sourcing Desk Response
CAS #24666-56-6 / 98475-07-1
Lenalidomide pharmaceutical synthesis intermediates
Crystalline Powder Analytical Verification

Product Overview

Technical profile, constituent properties and sourcing coordination

Sourcing Portfolio

Our Lenalidomide Intermediate Range

  • 1. 3-Aminopiperidine-2,6-dione Hydrochloride (CAS: 24666-56-6): A heterocyclic intermediate used in Lenalidomide synthesis. Its functionalized piperidinedione structure makes it a relevant building block for pharmaceutical synthesis and process development.
    Applications: Lenalidomide synthetic route development, pharmaceutical intermediate processing, API process research, commercial synthesis programs.
  • 2. Methyl 2-(Bromomethyl)-3-nitrobenzoate (CAS: 98475-07-1): An aromatic intermediate used in synthetic routes associated with Lenalidomide. Its bromomethyl functionality makes it useful for further chemical transformations during intermediate synthesis.
    Applications: Lenalidomide intermediate synthesis, pharmaceutical process development, advanced chemical synthesis, R&D and commercial procurement.

Product Specifications

Analytical parameters, chemical identity and batch verification

Specification-Based
Parameter Intermediate 1 Intermediate 2
Name 3-Aminopiperidine-2,6-dione Hydrochloride Methyl 2-(Bromomethyl)-3-nitrobenzoate
CAS 24666-56-6 98475-07-1
Category Heterocyclic Intermediate Aromatic Intermediate
Intended Use Lenalidomide Synthesis Lenalidomide Synthesis
Grade Confirm per product Confirm per product
Assay Confirm per product Confirm per product
Appearance Confirm per product Confirm per product

The live page lists ≥98.5% assay and crystalline powder for the combined portfolio. These are not confirmed separately for each intermediate in the client document.

Final grade, assay and batch specifications require confirmation against current manufacturer documentation and Certificates of Analysis.

Formulation & Synthesis Applications

Targeted applications across pharmaceutical synthesis, nutraceuticals & research

Multi-Industry Scope

Lenalidomide API Synthesis

Both compounds are relevant to synthetic pathways associated with Lenalidomide.

Pharmaceutical Process Development

These intermediates support route evaluation, chemical process development and intermediate-stage synthesis.

Commercial API Manufacturing Programs

The materials may be sourced for pharmaceutical manufacturing requirements, subject to product specifications and source availability.

* Note: Application descriptions are for informational and technical evaluation purposes and should not be interpreted as claims to diagnose, treat, or cure disease.

Quality & Documentation Support

Analytical verification, regulatory coordination & technical records

QA Verification

Pharmabridge assists buyers with product-specific specifications, analytical information and available quality documentation.

Because the two intermediates are different compounds, each should have its own material identity, analytical specification and batch documentation.

Available Records (On Request)

  • Batch Certificate of Analysis (CoA)
  • HPLC / Analytical Assay Methodology
  • Safety Data Sheet (SDS / MSDS)
  • Impurity & Residual Solvent Information

Why Choose Pharmabridge?

Specialized portfolio, specification alignment and procurement expertise

Sourcing Excellence
01

Focused Lenalidomide intermediate portfolio

02

CAS-specific sourcing enquiries

03

Documentation coordination

04

Support for research and commercial procurement

Frequently Asked Questions

Clear answers to technical, analytical and commercial sourcing questions

8 Clarifications
They are chemical building blocks used during the synthesis of Lenalidomide API.
The current range includes 3-Aminopiperidine-2,6-dione Hydrochloride and Methyl 2-(Bromomethyl)-3-nitrobenzoate.
Its CAS number is 24666-56-6.
Its CAS number is 98475-07-1.
No. They are chemical intermediates used in synthesis and should not be represented as finished Lenalidomide API.
Not necessarily. Product-specific assays must be confirmed separately.
Customers can request available batch-specific analytical documentation during the sourcing enquiry.
Specify the required intermediate, CAS number, quantity, assay requirements and documentation needs.
Enquire About Lenalidomide Intermediates – Pharmaceutical Synthesis Building Blocks

Looking for Lenalidomide Intermediates – Pharmaceutical Synthesis Building Blocks for Your Project?

Contact Pharmabridge with your required compound, desired assay, grade, target quantity and documentation needs. Our sourcing team coordinates specifications and commercial terms promptly.

Speak to Sourcing Desk

Quick Sourcing Enquiry

24h Technical Response Desk
100% Confidential • Direct Sourcing Desk